To the best of our knowledge, our study provides the first evidence that the administration of Bry‐1 could significantly ameliorate spontaneous CD‐like enteritis in Il‐10−/− mice, as demonstrated by decreases in the DAI, inflammatory score and proinflammatory mediator levels. The gene discussed is IL10; the disease is enteritis.